“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives
Role Overview & Key Functions: RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL is responsible for building relationships with gynecologic
Role Overview & Key Functions: RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL is responsible for building relationships with gynecologic
Role Overview & Key Functions: RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL is responsible for building relationships with gynecologic
Role Overview & Key Functions: The Medical Science Liaison (MSL), Hematology serves as Karyopharm’s field-based scientific expert supporting multiple myeloma and emerging hematology programs, including potential future indications in myelofibrosis. The MSL is responsible for developing and maintaining
Role Overview & Key Functions: The Medical Science Liaison (MSL), Hematology serves as Karyopharm’s field-based scientific expert supporting multiple myeloma and emerging hematology programs, including potential future indications in myelofibrosis. The MSL is responsible for developing and maintaining
Role Overview & Key Functions: RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL is responsible for building relationships with gynecologic
Role Overview & Key Functions: RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL is responsible for building relationships with gynecologic
Role Overview & Key Functions: RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL is responsible for building relationships with gynecologic
Role Overview & Key Functions: The Medical Science Liaison (MSL), Hematology serves as Karyopharm’s field-based scientific expert supporting multiple myeloma and emerging hematology programs, including potential future indications in myelofibrosis. The MSL is responsible for developing and maintaining
Role Overview & Key Functions: The Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL is responsible for building relationships with gynecologic
Role Overview & Key Functions: RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL is responsible for building relationships with gynecologic
Role Overview & Key Functions: RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL is responsible for building relationships with gynecologic
At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create,
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial
Job Description SummaryThe Medical Science Liaison (MSL) role is a field based, customer-facing, non-promotional medical and scientific position. The MSL’s key objective is to create impact through advancing clinical practice within the assigned territory that leads to improved